Impossible Foods is reportedly about to roll out a plant-based analogue chicken product, taking advantage of the surge in popularity of chicken at fast-food restaurants.
The company will introduce the product at a trade show this month and will roll it out commercially in the fall, according to Bloomberg.
The new product will not include “heme,” the ingredient derived from genetically modified yeast that gives Impossible’s analogue beef and pork products their meat-mimicking juiciness. The substance has led Impossible’s products to be banned from shipment to China and Europe, putting a serious crimp in the company’s overseas expansion plans.
Impossible is reportedly about to go public, the Bloomberg report says, and is seeking a valuation of about $10 billion.
